Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin mass drug administration for childhood mortality (MORDOR)
NCT02047981Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Dec 2014
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of azithromycin, sponsored by University of California, San Francisco. Started Dec 2014; status: completed.
02
Drugs
azithromycin
Beyond the preview
Go deeper on NCT02047981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02047981.